Bibliographic citations
Aguirre, J., (2023). Eficacia del Bypass gástrico en Y de Roux comparada con la gastrectomía vertical en manga en la remisión de Diabetes Mellitus Tipo 2: Revisión sistemática [Tesis, Universidad Privada Antenor Orrego - UPAO]. https://hdl.handle.net/20.500.12759/10064
Aguirre, J., Eficacia del Bypass gástrico en Y de Roux comparada con la gastrectomía vertical en manga en la remisión de Diabetes Mellitus Tipo 2: Revisión sistemática [Tesis]. PE: Universidad Privada Antenor Orrego - UPAO; 2023. https://hdl.handle.net/20.500.12759/10064
@misc{renati/371437,
title = "Eficacia del Bypass gástrico en Y de Roux comparada con la gastrectomía vertical en manga en la remisión de Diabetes Mellitus Tipo 2: Revisión sistemática",
author = "Aguirre Talledo, Joanna Celestina",
publisher = "Universidad Privada Antenor Orrego - UPAO",
year = "2023"
}
To determine if the Roux-en-Y gastric bypass is more effective than vertical sleeve gastrectomy in the remission of type 2 diabetes mellitus. Methods: A systematic review and meta-analysis was carried out, the search for the literature was carried out in 4 Web of Science, Medline/PubMed, Embase, Scopus and Medline/Ovid databases, 1323 results were identified, later the screening was carried out and obtained14 articles selected and included in the systematic review. The main and secondary outcomes were measured through a RR with a 95% CI. Results: The main outcome of T2DM remission was 15% in favor of VSG, RR: 1.15; [95% CI: 1.04 – 1.28]. For secondary outcomes, AHT remission was 7% in favor of ESR RR: 1.07; [95% CI: 1.00 – 1.16]. Dyslipidemia remission was 16% in favor of ESR RR: 1.16; [95% CI: 1.06 – 1.26]. For excess weight loss, it was in favor of ESR with an MD: 6.50; [95% CI: 4.99 – 8.01]. The remission of the drug in the short-term subgroup in favor of ESR, RR: 1.05; [95% CI: 0.80 – 1.39], medium term in favor of RYGB, RR: 0.97; [95% CI: 0.77 – 1.23], an indeterminate result is concluded. For the variable use of insulin, it will be produced that the reduction in the use of insulin was favorable for the RYGB group with a RR: 0.96; [95% CI 0.88 – 1.04]. Conclusion: Laparoscopic sleeve gastrectomy is more effective in DM2 remission, AHT remission, dyslipidemia remission, weight loss compared to Roux-en-Y gastric bypass.
This item is licensed under a Creative Commons License